Last updated on November 2017

An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder


Brief description of study

An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder

Detailed Study Description

The purpose of this study is to evaluate the efficacy of sirukumab as adjunctive treatment to antidepressant therapy, where sirukumab is measured over a 12 week study period for treatment of depression symptoms.

Clinical Study Identifier: TX14533

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

CNS

Collaborative Neuro Science Network
Garden Grove, CA USA
  Connect »